Home›Companies›Biotech & Pharma›Renosome Bio

Renosome Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 23, 2024·Suggest an edit

About Renosome Bio

Renosome Bio is a private company based in Manchester, Connecticut, incorporated in 2024 in Delaware. It has reported $150,000 raised in one offering on Form D since October 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 8, 2024Oct 23, 2024$150,000of $1.0M target5$30,000Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Renosome Bio's Form D filed Oct 23, 2024.

AK
Adam Kievman
President and director

Sources

  1. SECRenosome Bio, Inc. filing history